Company / Accounts Receivable
RAPID MICRO BIOSYSTEMS, INC. Accounts Receivable History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$3.1M
FY2025
5-year range
$3.1M / $7.5M
FY2021-FY2025
Trend
-58.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $6M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2025 with a 3-year CAGR of -16.4%.
Declined from $6M to $3M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -16.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -16.4%, indicating a declining trend.
- In FY2025, accounts receivable decreased 58.3% year-over-year.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -64.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1M | -58.3% |
| FY2024 | $7.5M | +35.9% |
| FY2023 | $5.5M | +3.0% |
| FY2022 | $5.4M | +7.3% |
| FY2021 | $5.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026